• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Novo Nordisk

NYSE:NVO

$140.61 $0.70 (0.50%)

REAL-TIME: Last trade at

Jump to this page for:

Related Resources

European Regulators Positive On Novo Nordisk Bleeding Disorder Product

5/25/2012 by Smart Money

Forget About Facebook And Buy These 10 Foreign Stocks

5/24/2012 by Seeking Alpha

Johnson & Johnson: An Uncommon Opportunity

5/24/2012 by Seeking Alpha

WSJ BLOG/Health: A.M. Vitals: Anticipating the Health Law Ruling

5/23/2012 by Smart Money

NVO's Levemir Label Expanded - Analyst Blog

5/23/2012 by Nasdaq

Europe stocks inch higher in a choppy market

5/9/2012 by MarketWatch

Political uncertainty rattles Europe stock markets

5/7/2012 by MarketWatch

Novo Nordisk Buys Back Shares Worth DKK4.2 Billion As Part Of Programme

5/2/2012 by Smart Money

Will Novo Nordisk Help You Retire Rich?

5/1/2012 by DailyFinance

1 Biotech Maximizing Shareholder Value

5/1/2012 by DailyFinance

NVO Kicks Off 2012 on a Strong Note - Analyst Blog

4/30/2012 by Nasdaq

UPDATE: Novo Nordisk Misses Views, Shares Fall

4/27/2012 by Smart Money

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO

4/27/2012 by 247wallst

Novo Nordisk Chairman To Step Down In 2013, Goran Ando To Replace

4/27/2012 by Smart Money

Novo Nordisk, Oxford University In Joint Drug Devt Deal

4/24/2012 by Smart Money

WSJ BLOG/Health: A.M. Vitals: Kentucky Considers New Rules for Pain Clinics

4/20/2012 by Smart Money

Europe stocks rise as banks rally after German Ifo

4/20/2012 by MarketWatch

Europe stocks rise ahead of auctions; Spain off

4/19/2012 by MarketWatch

FDA Is Asked To Remove Novo Nordisk Diabetes Drug From Market

4/19/2012 by Smart Money

UPDATE: FDA Is Asked To Remove Novo Nordisk Diabetes Drug From Market

4/19/2012 by Smart Money

UPDATE: Supreme Court Sides With Generic Drug Makers In Legal Tactics Case

4/17/2012 by Smart Money

2nd UPDATE:Top Court Sides With Generic Drug Makers In Tactics Case

4/17/2012 by Smart Money

4-Star Stocks Poised to Pop: Novo Nordisk

4/10/2012 by DailyFinance

Novo Nordisk, a Pharma Player in the Sweet Spot of an 'Endless' Market

4/9/2012 by Minyanville

Top Analyst Upgrades & Downgrades (AIG, BV, BIIB, BX, CIEN, IBM, MCD, NVO, SNDK, SON, LUV, SBUX, SYY

4/4/2012 by 247wallst

GSK Reports Data on Diabetes Drug - Analyst Blog

4/4/2012 by Nasdaq

12 Healthcare Dividend Stocks With Gaining Earnings Momentum

4/2/2012 by Trefis

Novo Nordisk Plays Down Concerns Over US Approval Of Obesity Drug - Report

4/2/2012 by Smart Money

Buyout Rumor Has Investors' Blood Sugar Pumping

3/29/2012 by DailyFinance

Pfizer's $200 Million Mistake

3/14/2012 by DailyFinance

Hinging Hopes on Faith-Based Investing

3/7/2012 by DailyFinance

Risk-Reward Balanced at Alkermes - Analyst Blog

3/6/2012 by Nasdaq

TIP SHEET: Goldman Rolls Out Income Fund Targeting 10% Dividend Growth

3/6/2012 by Smart Money

7 High Profitable Healthcare Dividend Stocks With Fantastic Yields

3/2/2012 by Trefis

1 Thing to Know Before Betting on the Next Blockbuster Drug

2/25/2012 by DailyFinance

Down 35%, Mannkind No Bargain

2/23/2012 by DailyFinance

Amylin's Bydureon Launches in the US - Analyst Blog

2/15/2012 by Nasdaq

This Just In: Upgrades and Downgrades

2/14/2012 by DailyFinance

YCHART OF THE DAY: Facebook’s $75-100 Billion Market Cap on Just $6.3 Billion in Assets: Customers C

2/7/2012 by YCharts

Why Did My Stock Just Die?

2/6/2012 by DailyFinance
See More Articles...